Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 ISIN · KYG1609T1022 HKEX Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2021-10-17 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
Stabilizing Actions, End of Stabilization Period and Lapse of the Over-Allotment Option
Capital/Financing Update Classification · 95% confidence The document is an announcement related to the stabilization actions, end of stabilization period, and lapse of the over-allotment option following a global offering of shares by Broncus Holding Corporation. It discusses details about share over-allocation, borrowing shares to cover over-allocations, market purchases to return borrowed shares, and the lapse of the over-allotment option. The document references the Securities and Futures (Price Stabilizing) Rules and is clearly related to capital market activities following an IPO or share offering. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is an update on capital market activities and share issuance related to the company's financing. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is over 6000 characters and contains substantive information about the capital event, not just a brief notice or report publication announcement.
2021-10-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on share capital, issued shares, share options, and confirmations related to securities issued by Broncus Holding Corporation. It includes data on authorized and issued shares, share options, and confirmations by the company secretary. The document is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. It is not an annual or quarterly financial report, nor is it an earnings release or management discussion. It is not a proxy statement, AGM material, or a legal proceeding report. The content is focused on share capital movements and confirmations related to securities issuance, which aligns with announcements regarding share capital changes or share issues. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length (9427 characters) and detailed data support it being a substantive report rather than a brief announcement or certification.
2021-10-07 English
VOLUNTARY ANNOUNCEMENT BRONCUS COMPLETED THE FIRST-IN-MAN CLINICAL TRIAL OF ITS TARGETED LUNG DENERVATION RADIOFREQUENCY ABLATION SYSTEM
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Broncus Holding Corporation about the completion of a first-in-man clinical trial of a medical device. It contains no financial data, no regulatory form references, no voting results, no management changes, no earnings or financial report content. The length is under 5,000 characters and it is an announcement of a clinical trial milestone, not a financial or governance report. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a general company announcement about a clinical development event. Such announcements typically fall under Regulatory Filings (RNS) as they are miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-30 English
Notification Letter and Request Form to Non-Registered Holders
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 30 September 2021 from Broncus Holding Corporation informing non-registered shareholders about the publication of the company's Interim Report 2021. It provides instructions on how to access the report online and how to request a printed version. The document does not contain the actual interim report or substantive financial data but serves as a notice of the report's availability. The document length is 8777 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Interim Report (IR).
2021-09-30 English
Interim Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled '2021 Interim Report' and contains detailed sections including Management Discussion and Analysis, Interim Condensed Consolidated Financial Statements, and Notes to Interim Condensed Consolidated Financial Information. It covers a period shorter than a full fiscal year (interim period) and includes substantive financial data and analysis. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content and structure align with an Interim / Quarterly Report rather than an Annual Report or Earnings Release. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2021
2021-09-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles and functions, including committee memberships. It does not contain financial data, earnings, or report content. It is an announcement related to the company's board structure and management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming it is not a full report or other filing type.
2021-09-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.